One-year results from SOURCE XT — one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date — reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, with high rates of device success for all access approaches, valve sizes and delivery systems.
Fuente : http://www.eurekalert.org/pub_releases/2013-05/eso…
Hacer un comentario